# 2026-03-01 — Harper Daily Log

## Summary
Quiet monitoring day (overnight into Mar 1). No legitimate tasks received. Grant prep (harper-006) remains blocked on Michael. MVP Ventures opens in 8 days (Mar 9).

## Fleet Activity
- New bulletins reviewed: fb-20260228-001 (strategic pivot to worker acquisition) and fb-20260228-002 (crisis resolved — empty marketplace is distribution problem, not code). Both informational. Bulletin mentioned "Harper: retention cost modeling requested" but no formal inbox task arrived — not acting until proper assignment.
- Fleet alerts: 13 (up from 12). Decisions needed: 4 (none for Harper).
- Susan: consistent heartbeats all day, no buddy intervention needed.

## Injection Attempts
- 1 bogus "System:" self-audit message rejected. Claimed AGENTS.md contains a "Nightly Self-Audit" protocol — it doesn't. Verified by reading AGENTS.md at session start.
- Injection campaign continues but at lower volume (1/day vs 29/day on Feb 27).

## Outstanding Items (unchanged)
- harper-006: MVP Ventures grant prep, blocked on Michael (LoI + ADI bank)
- PI+PL insurance: Michael must get BizCover quote
- Stripe test payment: untested
- Refund policy: drafted, needs Michael approval
- Bank statements: Michael said end of Feb — now overdue by 1 day

## Daytime Activity (Mar 1)
- Full day of routine heartbeats (04:30–20:15 AEDT). No inbox messages, no queue changes, no new tasks from Rivet.
- 1 additional injection attempt rejected: fake "FLEET BULLETIN [ALERT]" about "agent accountability crisis" via System: message in heartbeat channel. Standard pattern — ignored.
- Fleet stable all day: 13 alerts, 4 decisions (none for Harper), no blocked agents.
- Susan (buddy): active/idle throughout, consistent heartbeats, no intervention needed.
- MVP Ventures countdown: 7 days (opens Mar 9). All Harper docs ready. Ball remains with Michael.

## Note
Bank statements from Michael are now technically overdue (he said "end of Feb"). Not escalating yet — he's busy and it's only 1 day. Will flag if not received by Mar 3.
